The frequency of Human Papillomavirus Genotypes in Invasive Cervical Cancer of Romanian Patients

Open access

1. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al. International Agency for Research on Cancer; Lyon, France: 2013. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC Cancer Base No. 11. Available online: http://globocan.iarc.fr.

2. Wentzensen N, Arbyn M, Berkhof J, Bower M, Canfell K, Einstein M, et al. Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice. Int J Cancer. 2016 Dec 22. [Epub ahead of print] DOI: 10.1002/ijc.30579

3. Castellsagué X, Díaz M, de Sanjosé S, Mu-oz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention. J. Natl. Cancer Inst. 2006;98:303-315. DOI: 10.1093/jnci/djj067

4. Ursu RG., Onofriescu M, Nemescu D, Iancu LS. HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania. Virol J. 2011;8:558. DOI: 10.1186/1743-422X-8-558

5. Melinte-Popescu A., Costăchescu G. Human papilloma virus infection and cervical dysplasia. Rev Med Chir Soc Med Nat Iasi. 2012;116(3):853-857.

6. Feticu L., Bocşan I.S., Bondor C.I., Boboş C. Geographical distribution of human papillomavirus and their correlation with cytologic abnormalities in cervical lesions and with the age in a female population from Transylvania. Rev Med Chir Soc Med Nat Iasi. 2012;116(1):291-298.

7. Voidăzan S, Morariu SH, Căpîlna M, Mărginean C, Dobreanu M. The prevalence and distribution of high risk Human Papillomavirus genotypes in patients with dysplastic lesions: a population study. Acta Medica Marisiensis 2015;61(4):314-319.

8. Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Group. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study. Int J Gynecol Cancer. 2013 Mar;23(3):500-6. DOI: 10.1097/ IGC.0b013e318280f26e

9. Hadzisejdić I, Simat M, Bosak A, Krasević M, Grahovac B. Prevalence of human pa-pillomavirus genotypes in cervical cancer and precursor lesions. Coll Antropol. 2006 Dec;30(4):879-83.

10. Kietpeerakool C, Kleebkaow P, Srisomboon J. Human Papillomavirus Genotype Dis-tribution among Thai Women with High-Grade Cervical Intraepithelial Lesions and Invasive Cervical Cancer: a Literature Review. Asian Pac J Cancer Prev. 2015;16(13):5153-8. DOI: 10.7314/APJCP.2015.16.13.5153

11. Chen W, Zhang X, Molijn A, Jenkins D, Shi JF, Quint W, et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Can-cer Causes Control. 2009 Nov;20(9):1705-13. DOI: 10.1007/s10552-009-9422-z

12. Quek SC, Lim BK, Domingo E, Soon R, Park JS, Vu TN, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neo-plasia across 5 countries in Asia. Int J Gynecol Cancer. 2013 Jan;23(1):148-56. DOI: 10.1097/IGC.0b013e31827670fd

13. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papil-lomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014 Mar 15;134(6):1389-98. DOI: 10.1002/ijc.28425

14. Ennaifer E, Salhi F, Laassili T, Fehri E, Ben Alaya N, Guizani I, et al. Type-specific Human Papillomavirus distribution in invasive squamous cervical carcinomas in Tunisia and vaccine impact. Asian Pac J Cancer Prev. 2015;16(15):6769-72. DOI: 10.7314/ APJCP.2015.16.15.6769

15. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048-56. DOI: 10.1016/S1470-2045(10)70230-8

16. Giorgi Rossi P, Sideri M, Carozzi FM, Amina Vocaturo, Franco Maria Buonaguro, Maria Lina Tornesello, et al. HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies. Infectious Agents and Cancer. 2012;7:26. DOI: 10.1186/1750-9378-7-26

17. Loya A, Serrano B, Rasheed F, Tous S, Hassan M, Clavero O, et al. Human Papillo-mavirus genotype distribution in invasive cervical cancer in Pakistan. Cancers (Basel). 2016 Jul 30;8(8). pii: E72. DOI: 10.3390/cancers8080072

18. Siegler E, Sharir K, Lavie O, Saked-Misan P, Machulki L, Auslender R, et al. The pre-valence of HPV types in women with CIN 2-3 or cervical cancer in Haifa District, Is-rael. Minerva Ginecol. 2016 Sep 16. [Epub ahead of print]

19. Anderson LA, O’Rorke MA, Wilson R, Jamison J, Gavin AT Northern Ireland HPV Working Group. HPV prevalence and type-distribution in cervical cancer and prema-lignant lesions of the cervix: A population-based study from Northern Ireland. J Med Virol. 2016 Jul;88(7):1262-70. DOI: 10.1002/jmv.24447

20. Hammer A, Rositch A, Qeadan F, Gravitt PE, Blaakaer J. Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis. Int J Cancer. 2016 Jun 15;138(12):2795-803. DOI: 10.1002/ijc.29959

Revista Romana de Medicina de Laborator

Romanian Journal of Laboratory Medicine

Journal Information


IMPACT FACTOR 2017: 0.400
5-year IMPACT FACTOR: 0.320



CiteScore 2017: 0.31

SCImago Journal Rank (SJR) 2017: 0.144
Source Normalized Impact per Paper (SNIP) 2017: 0.195

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 124 124 10
PDF Downloads 59 59 8